Protease-activated receptor 2-mediated vasodilatation in humans in vivo: role of nitric oxide and prostanoids
about
sameAs
Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic ReviewProtection of protease-activated receptor 2 mediated vasodilatation against angiotensin II-induced vascular dysfunction in miceEffect of PAR2 in regulating TNF-α and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice.Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.Distinct roles of protease-activated receptors in signal transduction regulation of endothelial nitric oxide synthase.Modulation of PAR(1) signalling by benzimidazole compounds.Trypsin induces epidermal proliferation and inflammation in murine skin.Small caliber arterial endothelial cells calcium signals elicited by PAR2 are preserved from endothelial dysfunction.Proteinase-activated receptor 2 activation modulates guinea-pig mesenteric lymphatic vessel pacemaker potential and contractile activity.Hyperpolarization of murine small caliber mesenteric arteries by activation of endothelial proteinase-activated receptor 2.Activation of protease-activated receptor 2 mediates cutaneous vasodilatation but not sweating: roles of nitric oxide synthase and cyclo-oxygenase.Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy.Effects of chronic in-vivo treatments with protease-activated receptor 2 agonist on endothelium function and blood pressures in mice.Involvement of proteinase activated receptor-2 in the vascular response to sphingosine 1-phosphate.The effect of exogenous activation of protease-activated receptor 2 on cutaneous vasodilatation and sweating in young males during rest and exercise in the heat
P2860
Q26752383-FC1472DC-6F95-4A3C-8171-2FAC7CCA53F9Q34034013-34046734-9ECA-4714-8EAC-7B765424B9D5Q35128047-D1550F22-A0AE-452B-B314-3112FE3FFCD4Q37024500-BEB3813E-3E8B-4CA8-B106-5FCE4B5CD01DQ37184617-730F6006-0FD2-4D44-A280-6DAF9624DD19Q39361791-4695D253-5B0E-4F18-9E8E-F7D347F0D59CQ40566589-F61BA768-70A2-483F-9A3C-26A79DA914DFQ42256775-0F840815-3193-44FD-A8B0-EECAD1834057Q45032603-66006D15-12DF-4393-A378-0EE67E69A473Q45220380-A3F793B2-6C7C-4FC7-A07A-5257C4BBDC18Q48146808-F555E755-441A-4403-A211-80454B340D26Q50002204-B57BA62A-BAEC-4A13-BE1C-2C7CFE25D6F0Q51032370-AC7227B6-6243-48C3-A166-1C52C4FFAC94Q54402593-3760B29C-A896-43A6-AEAC-5C06721E0C75Q58127314-C2574B6E-777B-4E04-9F02-334113EC4D03
P2860
Protease-activated receptor 2-mediated vasodilatation in humans in vivo: role of nitric oxide and prostanoids
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Protease-activated receptor 2- ...... f nitric oxide and prostanoids
@ast
Protease-activated receptor 2- ...... f nitric oxide and prostanoids
@en
Protease-activated receptor 2- ...... f nitric oxide and prostanoids
@nl
type
label
Protease-activated receptor 2- ...... f nitric oxide and prostanoids
@ast
Protease-activated receptor 2- ...... f nitric oxide and prostanoids
@en
Protease-activated receptor 2- ...... f nitric oxide and prostanoids
@nl
prefLabel
Protease-activated receptor 2- ...... f nitric oxide and prostanoids
@ast
Protease-activated receptor 2- ...... f nitric oxide and prostanoids
@en
Protease-activated receptor 2- ...... f nitric oxide and prostanoids
@nl
P2093
P1433
P1476
Protease-activated receptor 2- ...... f nitric oxide and prostanoids
@en
P2093
Jonathan Robin
Patrick Vallance
Peter Mclean
Richard Campbell
P356
10.1161/01.CIR.0000050620.37260.75
P407
P577
2003-02-25T00:00:00Z